Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Nonalcoholic Fatty Liver”

176 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 176 results

Not applicableStudy completedNCT04285554
What this trial is testing

Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Metavention 15
Large-scale testing (Phase 3)Study completedNCT02242149
What this trial is testing

Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects

Who this might be right for
Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver Disease
Universidade Federal do Rio de Janeiro 84
Post-approval studies (Phase 4)Ended earlyNCT02365233
What this trial is testing

Fatty Liver Study in Patients With Type II Diabetes

Who this might be right for
Type II DiabetesNonalcoholic Fatty Liver
The University of Texas Medical Branch, Galveston 5
Not applicableLooking for participantsNCT03875625
What this trial is testing

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesity, MorbidBrown Fat+4 more
Chinese University of Hong Kong 80
Not applicableLooking for participantsNCT06035874
What this trial is testing

Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNon Alcholic Fatty Liver Disease
Medanta, The Medicity, India 100
Post-approval studies (Phase 4)Study completedNCT02303730
What this trial is testing

Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver Disease
Fudan University 76
Post-approval studies (Phase 4)Study completedNCT00994682
What this trial is testing

University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)

Who this might be right for
Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
University of Florida 176
Not applicableStudy completedNCT05092399
What this trial is testing

Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesNAFLDObesity
University of Nottingham 21
Not applicableActive Not RecruitingNCT06445335
What this trial is testing

Prevalence of NAFLD in T2DM Patients

Who this might be right for
NAFLDT2DType 2 Diabetes+1 more
Ziekenhuis Oost-Limburg 385
Post-approval studies (Phase 4)Looking for participantsNCT05644717
What this trial is testing

Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD

Who this might be right for
Liver FatLiver FibrosisGlycemic Control+3 more
Getz Pharma 164
Not applicableStudy completedNCT04820556
What this trial is testing

Gut Microbiota in Chronic Noncommunicable Diseases

Who this might be right for
Arterial HypertensionAtherosclerosis Occlusive DiseaseHeart Failure With Preserved Ejection Fraction+5 more
National Medical Research Center for Therapy and Preventive Medicine 1,084
Not applicableStudy completedNCT07338331
What this trial is testing

Comparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease

Who this might be right for
Diabete Type 2Non Alcoholic Fatty Liver
Galala University 80
Not applicableStudy completedNCT02686476
What this trial is testing

Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes

Who this might be right for
Non Alcoholic Fatty Liver Disease
Medanta, The Medicity, India 100
Large-scale testing (Phase 3)Study completedNCT02929901
What this trial is testing

The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Nonalcoholic Fatty Liver
National Nutrition and Food Technology Institute 200
Not applicableStudy completedNCT03826381
What this trial is testing

NAFLD Among Patients With Type 2 Diabetes and CKD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseChronic Kidney DiseasesType2 Diabetes
Rigshospitalet, Denmark 100
Not applicableStudy completedNCT03165877
What this trial is testing

Effect of Low-glycemic Index Meals Intake on DM2 Women Under Metformin Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Universidad de Valparaiso 13
Post-approval studies (Phase 4)UnknownNCT02964715
What this trial is testing

The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesNAFLD
University of Malaya 25
Not applicableStudy completedNCT04241575
What this trial is testing

Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages

Who this might be right for
Fatty Liver, NonalcoholicDiabetes Mellitus, Type 2
Chinese University of Hong Kong 1,061
Testing effectiveness (Phase 2)Study completedNCT00323414
What this trial is testing

Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver

Who this might be right for
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 37
Post-approval studies (Phase 4)Study completedNCT07363707
What this trial is testing

A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.

Who this might be right for
NAFLD (Nonalcoholic Fatty Liver Disease)
Beni-Suef University 108
Load More Results